Causes of Cancer and Opportunities for Prevention

  • H. Vainio
  • E. Hietanen
Part of the Handbook of Experimental Pharmacology book series (HEP, volume 156)

Abstract

The global incidence of cancer is soaring due to the rapidly aging populations in most countries. In 2000, there were ten million new cancer cases, six million cancer deaths, and 22 million people living with cancer (Parkin 2001). By the year 2020, there will be an estimated 20 million new cancer patients each year. Almost three quarters of them will be living in countries that between them have less than 5% of the resources of cancer control (Sikora 1999).

Keywords

Obesity Hepatitis Europe Ozone Flavonoid 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bear WL, Teel RW (2000) Effects of citrus flavonoids on the mutagenicity of heterocyclic amines and oncytochrome P450 1A2 activity. Anticancer Res 20:3609–3614PubMedGoogle Scholar
  2. Bergström A, Hsieh CC, Lindblad P, Lu CM, Cook NR, Wolk A (2001) Obesity and renal cell cancer — a quantitative review. Br J Cancer 85(7):984–90PubMedCrossRefGoogle Scholar
  3. Bianchini F, Kaaks R, Vainio H (2002) Weight control and physical activity in cancer prevention. Obesity Review 3:5–8CrossRefGoogle Scholar
  4. Chan JM, Stampfer MJ, Giovannucci E, Gann PH, Ma J, Wilkinson P, Hennekens CH, Pollak M (1998) Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science 279:563–566PubMedCrossRefGoogle Scholar
  5. Doll R, Peto R (1981) The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst 66(6):1191–308PubMedGoogle Scholar
  6. Fitzgerald EF, Schell LM, Marshall EG, Carpenter DO, Suk WA (1998) Environmental pollution and child health in central and eastern Europe. Environ Health: Perspec 106:307–311CrossRefGoogle Scholar
  7. Hammons GJ, Fletcher JV, Stes KR, Smith EA, Balentine DA, Harbowy ME, Kadlubar FF (1999) Effects of chemoprotective agents on the metabolic activation of the carcinogenic arylamines PhIP and 4-aminobiphenyl in human and rat microsomes. Nutr Cancer 33:46–52PubMedCrossRefGoogle Scholar
  8. Hatch FT, Lightstone FC, Colvin ME (2000) Quantitative structure-activity relationship of flavonoids for inhibition of heterocyclic amine mutagenicity. Environ Mol Mutagen 35:279–299.PubMedCrossRefGoogle Scholar
  9. IARC Handbooks of Cancer Prevention (2002) Weight Control and Physical Activity Vol. 6. pp 1–315Google Scholar
  10. I ARC Handbooks of Cancer Prevention (2001) Sunscreens. Vol. 5, pp 1–193Google Scholar
  11. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans (2000) Ionizing radiation. Part I: X- and Gamma (γ)-Radiation, and Neutrons. Vol. 75 pp 1–491Google Scholar
  12. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans (1999) Hormonal Contraception and Post-menopausal Hormonal Therapy. Vol. 72 pp 1–629Google Scholar
  13. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans (1997) Some Pharmaceutical Drugs. Vol. 66 pp 1–514Google Scholar
  14. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans (1995) Human papillomaviruses . Vol. 64 pp 1–409Google Scholar
  15. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans (1994) Hepatitis Viruses. Vol. 59 pp 1–284Google Scholar
  16. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans (1994b) Schistosomes, Liver Flukes and Helicobacter pylori. Vol. 61 pp 1–270Google Scholar
  17. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans Tobacco smoking (1986) Vol. 38 pp 1–421Google Scholar
  18. Ikonen T, Matikainen M, Mononen N, Hyytinen ER, Helin HJ, Tommola S, Tammela TL, Pukkala E, Schleutker J, Kallioniemi OP, Koivisto PA (2001) Association of e-cadherin germ-line alterations with prostate cancer. Clin cancer Res 7:3465–3471PubMedGoogle Scholar
  19. Liu BQ, Peto R, Chen ZM, Boreham J, Wu YP, Li JY (1998) Emerging tobacco hazards in China: Retrospective proportional mortality study of one million deaths. BMJ 317(7140):1411–22PubMedCrossRefGoogle Scholar
  20. Martorell R, Khan LK, Hughes ML, Grummer-Strawn LM (2000), Obesity in women from developing countries Eur J Clin Nutr 54(3):247–52Google Scholar
  21. Parkin D.M. (2001) Global cancer statistics in the year 2000. Lancet Oncology 2:533–43PubMedCrossRefGoogle Scholar
  22. Paolini M, Cantelli-Forti G, Perocco P, Pedulli GF, Abdel-Rahman SZ, Legator MS (1999) Co-carcinogenic effect of β-carotene. Nature 398:760–761PubMedCrossRefGoogle Scholar
  23. Peto R, Lopez AD (2000) Future world-wide health effects of current smoking patterns. Critical Issues in Global Health. Koop, CE.; Pearson,C.E.; Schwarz, M.R. pp 154–161Google Scholar
  24. Peto J, Collins N, Barfoot R, Seal S, Warren W, Rahman N, Easton DF, Evans C, Deacon J, Stratton MR (1999) Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer. J Nat Cancer Inst 9:943–949CrossRefGoogle Scholar
  25. Pisani P, Bray F, Ferlay J, Parkin DM, (2001) Estimates of the world-wide prevalence of cancer for 25 sites in the adult population. Int J 94 (in press)Google Scholar
  26. Pisani P, Parkin DM, Munoz N, Ferlay J (1997) Infection and Cancer burden, Cancer and Infection: estimates of the attributable fraction in 1990 Cancer Epidemiol Biomarkers Prev 6:387–400Google Scholar
  27. Staff S, Isola JJ, Johannsson O, Borg AA, Tanner MM (2001) Frequent somatic loss of BRCA1 in breast tumors from BRCA2 germ-line mutation carriers and vice versa. Br J Cancer 19:1201–1205CrossRefGoogle Scholar
  28. Stattin P, Bylund A, Rinaldi S, Biessy C, Dechaud H, Stenman UH, Egevad L, Riboli E, Hallmans G, Kaaks R (2000) Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective study. J Natl Cancer Inst 92:1910–1917PubMedCrossRefGoogle Scholar
  29. Sugimura T (2000) Nutrition and dietary carcinogens. Carcinogenesis 21:387–395PubMedCrossRefGoogle Scholar
  30. Swisher E (2001) Hereditary cancers in obstetrics and gynecology. Clin Obstet Gynecol 44:450–463PubMedCrossRefGoogle Scholar
  31. Tejpar S, Cassiman JJ, Van Cutsem E (2001) The molecular basis of colorectal cancer. Acta Gastroenterol Belg 64:249–254PubMedGoogle Scholar
  32. Tsao H (2001) Genetics of non melanoma skin cancer. Arch Dermatol 137:1486–1492PubMedGoogle Scholar
  33. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, Taniyama K, Sasaki N, Schlemper T (2001) Helicobacter-pylori Infection and the development of gastric. Cancer N Engl J Med 345:784–789CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2003

Authors and Affiliations

  • H. Vainio
  • E. Hietanen

There are no affiliations available

Personalised recommendations